Cargando…
MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation
BACKGROUND: Hepatocellular carcinoma (HCC) remains a major global health burden due to its high prevalence and mortality. Emerging evidence reveals that microRNA (miRNA) plays a vital role in cancer pathogenesis and is widely involved in the regulation of signaling pathways via their targeting of do...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982593/ https://www.ncbi.nlm.nih.gov/pubmed/33763375 http://dx.doi.org/10.3389/fonc.2021.642030 |
_version_ | 1783667752644378624 |
---|---|
author | Hong, Yinghui Ye, Mingliang Wang, Fan Fang, Jun Wang, Chun Luo, Jie Liu, Jialiang Liu, Jing Liu, Lan Zhao, Qiu Chang, Ying |
author_facet | Hong, Yinghui Ye, Mingliang Wang, Fan Fang, Jun Wang, Chun Luo, Jie Liu, Jialiang Liu, Jing Liu, Lan Zhao, Qiu Chang, Ying |
author_sort | Hong, Yinghui |
collection | PubMed |
description | BACKGROUND: Hepatocellular carcinoma (HCC) remains a major global health burden due to its high prevalence and mortality. Emerging evidence reveals that microRNA (miRNA) plays a vital role in cancer pathogenesis and is widely involved in the regulation of signaling pathways via their targeting of downstream genes. MiR-21-3p, a liver-enriched miRNA, and SMAD7, the negative regulator of the TGF-β signaling pathway, likely exert a vital influence on HCC progression. AIMS: Here, we explore the role of the miR-21-3p-SMAD7/YAP1 axis on HCC pathogenesis. METHODS: MiRNA microarray analysis was performed for miRNA screening. The dual-luciferase assay was adopted for target verification. Expression of miRNA and related genes were quantified via qRT-PCR, western blotting, and immunohistochemical staining. Flow cytometry and the transwell migration assay were used to detail cell apoptosis, invasion and metastases. Rat models were established to explore the role of the miR-21-3p-SMAD7/YAP1 axis in hepatocarcinogenesis. Bioinformatics analysis was conducted for exploring genes of clinical significance. RESULTS: MiR-21-3p levels were found to be significantly elevated in hepatocellular carcinoma and indicate poor overall survival. High miR-21-3p levels were associated with advanced tumor stages (P = 0.029), in particular T staging (P = 0.026). Low SMAD7/high YAP1 levels were confirmed in both HCC and rat models with advanced liver fibrosis and cirrhosis. Besides, SMAD7 was demonstrated to be the direct target of miR-21-3p. The effect of MiR-21-3p on tumor phenotypes and YAP1 upregulation could be partly reversed via the restoration of SMAD7 expression in HCC cell lines. Overexpression of YAP1 after miR-21-3p upregulation promoted expression of nuclear transcription effector connective tissue growth factor. Co-survival analysis indicated that lower miR-21-3p/higher SMAD7 (P = 0.0494) and lower miR-21-3p/lower YAP1 (P = 0.0379) group patients had better overall survival rates. Gene Set Variation Analysis revealed that gene sets related to miR-21-3p and SMAD7 were significantly associated with the TGF-β signaling pathway in HCC. CONCLUSION: MiR-21-3p promotes migration and invasion of HCC cells and upregulation of YAP1 expression via direct inhibition of SMAD7, underscoring a major epigenetic mechanism in the pathogenesis of HCC. |
format | Online Article Text |
id | pubmed-7982593 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79825932021-03-23 MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation Hong, Yinghui Ye, Mingliang Wang, Fan Fang, Jun Wang, Chun Luo, Jie Liu, Jialiang Liu, Jing Liu, Lan Zhao, Qiu Chang, Ying Front Oncol Oncology BACKGROUND: Hepatocellular carcinoma (HCC) remains a major global health burden due to its high prevalence and mortality. Emerging evidence reveals that microRNA (miRNA) plays a vital role in cancer pathogenesis and is widely involved in the regulation of signaling pathways via their targeting of downstream genes. MiR-21-3p, a liver-enriched miRNA, and SMAD7, the negative regulator of the TGF-β signaling pathway, likely exert a vital influence on HCC progression. AIMS: Here, we explore the role of the miR-21-3p-SMAD7/YAP1 axis on HCC pathogenesis. METHODS: MiRNA microarray analysis was performed for miRNA screening. The dual-luciferase assay was adopted for target verification. Expression of miRNA and related genes were quantified via qRT-PCR, western blotting, and immunohistochemical staining. Flow cytometry and the transwell migration assay were used to detail cell apoptosis, invasion and metastases. Rat models were established to explore the role of the miR-21-3p-SMAD7/YAP1 axis in hepatocarcinogenesis. Bioinformatics analysis was conducted for exploring genes of clinical significance. RESULTS: MiR-21-3p levels were found to be significantly elevated in hepatocellular carcinoma and indicate poor overall survival. High miR-21-3p levels were associated with advanced tumor stages (P = 0.029), in particular T staging (P = 0.026). Low SMAD7/high YAP1 levels were confirmed in both HCC and rat models with advanced liver fibrosis and cirrhosis. Besides, SMAD7 was demonstrated to be the direct target of miR-21-3p. The effect of MiR-21-3p on tumor phenotypes and YAP1 upregulation could be partly reversed via the restoration of SMAD7 expression in HCC cell lines. Overexpression of YAP1 after miR-21-3p upregulation promoted expression of nuclear transcription effector connective tissue growth factor. Co-survival analysis indicated that lower miR-21-3p/higher SMAD7 (P = 0.0494) and lower miR-21-3p/lower YAP1 (P = 0.0379) group patients had better overall survival rates. Gene Set Variation Analysis revealed that gene sets related to miR-21-3p and SMAD7 were significantly associated with the TGF-β signaling pathway in HCC. CONCLUSION: MiR-21-3p promotes migration and invasion of HCC cells and upregulation of YAP1 expression via direct inhibition of SMAD7, underscoring a major epigenetic mechanism in the pathogenesis of HCC. Frontiers Media S.A. 2021-03-08 /pmc/articles/PMC7982593/ /pubmed/33763375 http://dx.doi.org/10.3389/fonc.2021.642030 Text en Copyright © 2021 Hong, Ye, Wang, Fang, Wang, Luo, Liu, Liu, Liu, Zhao and Chang http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Hong, Yinghui Ye, Mingliang Wang, Fan Fang, Jun Wang, Chun Luo, Jie Liu, Jialiang Liu, Jing Liu, Lan Zhao, Qiu Chang, Ying MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation |
title | MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation |
title_full | MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation |
title_fullStr | MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation |
title_full_unstemmed | MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation |
title_short | MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation |
title_sort | mir-21-3p promotes hepatocellular carcinoma progression via smad7/yap1 regulation |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982593/ https://www.ncbi.nlm.nih.gov/pubmed/33763375 http://dx.doi.org/10.3389/fonc.2021.642030 |
work_keys_str_mv | AT hongyinghui mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation AT yemingliang mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation AT wangfan mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation AT fangjun mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation AT wangchun mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation AT luojie mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation AT liujialiang mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation AT liujing mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation AT liulan mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation AT zhaoqiu mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation AT changying mir213ppromoteshepatocellularcarcinomaprogressionviasmad7yap1regulation |